Predicting antiarrhythmic drug efficacy.

Abstract

For years, electrophysiologic testing was regarded as the best way to select effective pharmacologic therapy. But now it appears that Holter monitoring is just as accurate--as well as simpler, safer, and cheaper. Nevertheless, most patients eventually will need an electrophysiologic study because of the high rate of arrhythmia recurrence.